The Reinvention of Healthcare Marketing in the Age of Physician GPTs

The important shift is not simply that physicians are using AI. It is that they are beginning to think, search, and make decisions differently. Instead of navigating tabs, journals, search engines, treatment guidelines, and medical references, clinicians can now ask a single question and receive synthesized evidence, dosing guidance, trial data, reimbursement context, and treatment comparisons in seconds.That behavioral shift changes how healthcare marketing works. Historically, healthcare media has optimized around proxies for intent including search behavior, site visitation, content consumption, specialty targeting, claims data, conference attendance, and CRM engagement. Physician GPTs compress those signals into a single AI-driven interaction layer where discovery, evaluation, and decision-making increasingly happen at once. 

Physician GPTs introduce something far more valuable, by creating real-time clinical intent. 

When a verified physician asks: “How do biologics compare for moderate-to-severe asthma after ICS/LABA failure?” or “what are the latest treatment recommendations for pediatric AD patients with steroid concerns?”, the platform understands not only who they are, but also the precise context, decision stage, and information need in that moment. This creates one of the most signal-rich environments healthcare marketing has ever seen. 

Physician GPTs are not following the traditional media playbook.  Where endemic publishers historically scaled through reach, impression volume, sponsorships, and content adjacency, these platforms are positioning themselves as clinical workflow infrastructure. 

As a result, monetization models are being centered around:  

• Verified physician identity 

• Contextual clinical intent 

• “Decision journey” engagement over isolated impressions 

• Persistent sponsored visibility within conversations 

• Outcome-based measurement 

OpenEvidence exemplifies this shift, prioritizing clinical engagement quality over traditional media delivery. Early models like Cost Per Clinical Decision (CPCD) tie value to whether a physician is actively researching a relevant clinical topic at the moment of exposure-not just being served an ad.  

That distinction matters.Healthcare advertising has spent years trying to reduce waste across broad endemic environments where only a small percentage of impressions may align to actual prescribing consideration. Physician GPTs potentially compress that inefficiency dramatically, because the query itself becomes the targeting signal. 

The measurement implications are equally significant, and here’s why:  

Traditional HCP media has relied on lagging indicators – NBRx lift, script attribution, audience overlap, MMM models, and claims-based outcomes. Physician AI introduces a new middle layer built on real-time clinical intent signals: query engagement, treatment exploration, therapy comparison, educational progression, and persistence within diagnostic or therapeutic conversations. These environments effectively converge search, CRM, medical education, and point-of-care influence into a single experience.  

Based on our own early pilots and firsthand marketplace discussions, several important cautions have emerged: 

• Scale remains limited relative to broader endemic ecosystems, with query volume and repeat usage still developing. 

• Frequency management becomes critical, as repeated exposure is more noticeable in highly concentrated, workflow-embedded environments. 

• Trust and neutrality are paramount; overly intrusive or promotional experiences risk eroding adoption quickly.  

In the future, we’ll likely see physician GPT advertising move beyond traditional HCP display to experiences that are contextual, education, and embedded directly into clinical workflows – like trial summaries, MOA visualizations, formulary overlays, personalized education pathways, and conversational sponsored tools that support decision-making rather than interrupt it.  

For agencies and pharma marketers, this shifts the model from channel planning to workflow planning. The key question becomes not “Where can we reach physicians?” but “Where do physicians go to think?” 

This is why the convergence of SEM, SEO, GEO, AI discoverability, and clinical content strategy is increasingly critical.  At Havas, our One Search model reflects this new reality: discovery no longer happens in a single search box, but across an interconnected ecosystem of engines, assistants, communities, and AI-driven answer environments. Physicians now move fluidly across these touchpoints within a single decision journey.  

Our focus is ensuring brands are not just present, but discoverable, credible, and contextually relevant. Tools like BrandInsights.ai enable us to analyze how brands, treatments, and clinical topics show up across both traditional AI-driven environments, revealing visibility drivers, citation sources, competitive positioning, and gaps in authority. This shifts optimization from “winning the click” to shaping how brands are understood within the answer itself.  

As physician GPTs and clinical AI assistants evolve, discoverability will depend on structured content, scientific authority, entity development, citation strategy, and real-time contextual relevance. SEO, paid search, medical education, CRM, and point-of-care engagement are converging in a unified strategy designed not just for human search, but for AI systems to synthesize and recommend information.  

That is the foundation of One Search: a connected ecosystem where media, content, data, and AI optimization work together to maintain visibility wherever clinical decisions are being shaped. If AI increasingly synthesizes from trusted sources, then discoverability, structured medical content, and scientific credibility become core media considerations – not just content ones. Healthcare marketing is entering a phase where the lines between media, search, education, and clinical utility are disappearing. The Physician GPT ecosystem is still early. Measurement remains immature, pricing models are evolving, scale is uncertain, and regulatory and MLR frameworks will need to catch up quickly. 

But the trajectory is undeniable. The next era of healthcare advertising will not be defined by proximity to physician decision-making. It will be defined by participation within it. 

As brands, platforms, and healthcare marketers prepare for this shift, the opportunity will belong to those who understand how AI is reshaping clinical influence, engagement, and trust at the point of decision. To learn more about how Physician GPTs are redefining healthcare marketing strategy, reach out to Havas Media Network North American Managing Partner, Marketing & Communications,  Amanda Dyke, amanda.dyke@havasmedia.com